Skip to main content
. 2013 Nov 18;99(2):E303–E310. doi: 10.1210/jc.2013-1956

Figure 4.

Figure 4.

Effects of CS or CS with PRKAR1A mutations (mtCS) on the PKA signaling pathway were assessed in PAT by measuring PKA activity and cAMP levels. A–E, cAMP-stimulated PKA activity (A), basal PKA activity (B), the ratio of basal to total PKA activity (C), cAMP concentrations (D), and cAMP-stimulated DEAE assay (E) of PAT samples from CS and non-CS groups. Data presented are means ± SEM. *, P < .05.